NMTC NeuroOne Medical Technologies Corporation - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026
$1,12
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,5652 haftanın en düşüğü
$5,4052 haftanın en yükseği
Piyasa Değeri (MRQ)
$10M
P/E (TTM)
-1.7
Hisse Başına Kâr (TTM)
$-0.64
Gelir (TTM)
$9M
rozetleriniz
52 Haftlık Aralık
$1–$5
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$7
P/E
-1.7
ROE
-124.7%
Net Kâr Marjı
-78.6%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
NMTC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.12
Piyasa Değeri (MRQ)
$10M
P/E (TTM)
-1.7
Hisse Başına Kâr (TTM)
$-0.64
Gelir (TTM)
$9M
ROE (TTM)
-124.7%
52 Haftlık Aralık
$1–$5
NMTC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 16 Nisan 2026 | 1-for-6 | Ters |
| 01 Nisan 2021 | 1-for-3 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$9M2015-12-31 → 2025-09-30
Hisse Başına Kâr$-0.092021-09-30 → 2025-09-30
Serbest Nakit Akışı·2021-09-30 → 2024-09-30
Net kar marjı-78.6%2015-12-31 → 2024-09-30
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | NMTC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.75Y ort. ≈-4.1 | ≈-4.1 | · | · | |
| F/S (TTM) | 1.05Y ort. ≈111.5 | ≈111.5 | 3.1 | Adil değer | |
| F/D (MRQ) | 2.65Y ort. ≈12.7 | ≈12.7 | 2.9 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.45Y ort. ≈-3.3 | ≈-3.3 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.45Y ort. ≈-3.4 | ≈-3.4 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 2.65Y ort. ≈12.1 | ≈12.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | NMTC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 55.6%5Y ort. ≈-10.4% | ≈-10.4% | 60.7% | Aynı seviyede | |
| Faaliyet Kâr Marjı (TTM) | -83.4%5Y ort. ≈-3138.1% | ≈-3138.1% | -122.9% | Aynı seviyede | |
| Vergi Öncesi Kar Marjı (TTM) | -78.6% | · | -84.3% | Zayıf | |
| Net Kâr Marjı (TTM) | -78.6%5Y ort. ≈-3097.6% | ≈-3097.6% | -84.8% | Zayıf | |
| ROA (TTM) | -87.6%5Y ort. ≈-137.3% | ≈-137.3% | -49.7% | Aynı seviyede | |
| ROE (TTM) | -124.7%5Y ort. ≈-276.0% | ≈-276.0% | -100.3% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | NMTC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 2.85Y ort. ≈4.1 | ≈4.1 | 1.8 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | NMTC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 163.5%5Y ort. ≈319.3% | ≈319.3% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 276.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | NMTC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$505.4K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
4.5%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Eylül 2026 | $-0.28 | $-0.22 | -26.7% | |
| 30 Haziran 2026 | Ağu 13, 2026 | $-0.28 | $-0.22 | -26.7% |
| 31 Mart 2026 | $-0.25 | $-0.23 | -8.1% | |
| 31 Aralık 2025 | $-0.18 | $-0.24 | 26.5% | |
| 30 Eylül 2025 | $-0.24 | $-0.24 | 2.0% | |
| 30 Haziran 2025 | $-0.18 | $-0.31 | 41.2% | |
| 31 Mart 2025 | $-0.07 | $-0.09 | 23.7% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $3M | $2M | $171.2K | $178.1K | · | · | · | · | $0 | $0 | $773 | |
| Cost of Revenue | $4M | $2M | $1M | $242.0K | $275.9K | · | · | · | · | · | · | · | |
| Gross Profit | $5M | $1M | $456.5K | $-70.8K | $-97.7K | · | · | · | · | · | · | · | |
| R&D Expense | $5M | $5M | $7M | $5M | $4M | $2M | $2M | · | · | · | · | · | |
| SG&A Expense | $7M | $8M | $7M | $7M | $6M | $5M | $4M | · | · | $32.6K | $30.9K | $36.7K | |
| Operating Expenses | $12M | $13M | $14M | $12M | $10M | $7M | $6M | · | · | $32.6K | $30.9K | $36.7K | |
| Operating Income | $-4M | $-12M | $-12M | $-10M | $-10M | $-5M | $-6M | · | · | $-32.6K | $-30.9K | $-35.9K | |
| Interest Expense | · | · | · | · | $3.1K | · | · | · | · | · | $14.0K | $330 | |
| Other Non-op | · | $125.2K | $95.8K | $31.2K | · | · | · | · | · | · | · | · | |
| Pretax Income | $-4M | $-12M | $-12M | $-10M | · | $-2M | · | · | · | $-32.6K | $-30.9K | $-36.2K | |
| Income Tax | · | · | · | · | $-271.1K | · | · | · | · | $0 | $0 | $0 | |
| Net Income | $-4M | $-12M | $-12M | $-10M | $-10M | $-14M | $-7M | · | · | $-47.8K | $-62.9K | $-36.2K | |
| EPS (Basic) | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 | · | · | · | · | · | · | · | |
| Shares (Basic) | 40,152,873 | 26,762,392 | 18,121,108 | 15,998,567 | 10,696,799 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 40,152,873 | 26,762,392 | 18,121,108 | 15,998,567 | 10,696,799 | · | · | · | · | · | · | · | |
| EBITDA | · | $-12M | $-12M | $-10M | $-10M | · | · | · | · | $-32.6K | $-48.8K | $-35.9K |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $1M | $5M | $8M | $7M | $4M | $260.7K | $13.3K | $26.5K | $0 | $0 | $205 | |
| Short-term Investments | · | · | · | $3M | · | · | · | · | · | · | · | · | |
| Receivables | $1M | $176.6K | · | $33.2K | $48.3K | · | · | · | · | · | $0 | $0 | |
| Inventory | $2M | $3M | $2M | $704.5K | $98.3K | · | · | · | · | · | · | · | |
| Prepaid Expense | $141.4K | $216.5K | $263.7K | $296.6K | $244.0K | $118.6K | $41.0K | $5.4K | · | · | · | · | |
| Current Assets | $10M | $5M | $7M | $12M | $7M | $4M | $301.8K | $18.6K | · | · | $1.8K | $205 | |
| PP&E (Net) | $259.2K | $416.8K | $525.8K | $353.6K | $223.3K | $166.0K | $52.0K | · | · | · | · | · | |
| PP&E (Gross) | $1M | $976.3K | $860.7K | $539.96B | $313.4K | $197.7K | $58.4K | · | · | · | · | · | |
| Accum. Depreciation | $798.8K | $559.5K | $335.0K | $186.36B | · | $31.6K | $6.3K | · | · | · | · | · | |
| Intangibles | $44.9K | $67.3K | $89.6K | $111.9K | $134.2K | $156.5K | $178.8K | $200.1K | · | · | · | · | |
| Total Assets | $11M | $5M | $8M | $13M | $8M | $5M | $532.6K | $218.7K | · | $4.3K | $1.8K | $205 | |
| Accounts Payable | $1M | $1M | $685.1K | $927.7K | $528.8K | $762.5K | $1M | $221.2K | · | $22.4K | $10.9K | $10.0K | |
| Accrued Liabilities | $1M | $1M | $1M | $715.8K | $644.2K | $512.8K | $617.7K | $2M | · | $0 | $0 | $3.0K | |
| Short-term Debt | · | · | $129.1K | · | · | $1M | · | · | · | · | · | · | |
| Current Liabilities | $2M | $2M | $2M | $3M | $1M | $2M | $2M | $4M | · | $117.9K | $83.3K | $35.6K | |
| Capital Leases | $143.1K | $194.4K | $55.3K | $119.6K | $202.9K | $254.3K | · | · | · | · | · | · | |
| Total Liabilities | $4M | $5M | $2M | $3M | $1M | $3M | $2M | $5M | · | $117.9K | $83.3K | $35.6K | |
| Common Stock | $8.3K | $30.8K | $23.9K | $16.2K | $12.0K | $22.2K | $13.5K | $9.7K | · | $5.1K | $5.1K | $5.1K | |
| Paid-in Capital | $86M | $76M | $69M | $60M | $47M | $33M | $16M | $6M | · | $45.6K | $45.6K | $76.7K | |
| Retained Earnings | $-79M | $-75M | $-63M | $-51M | $-41M | $-31M | $-17M | $-10M | · | $-164.3K | $-180.0K | $-117.2K | |
| Stockholders' Equity | $7M | $822.0K | $6M | $10M | $7M | $2M | $-1M | $-4M | $-5M | $-113.7K | $-81.5K | $-35.4K | |
| Liabilities + Equity | $11M | $5M | $8M | $13M | $8M | $5M | $532.6K | $218.7K | · | $4.3K | $1.8K | $205 | |
| Shares Outstanding | 8,334,336 | 30,816,499 | 23,928,945 | 16,216,540 | 12,010,019 | 7,393,637 | 13,493,705 | 9,656,505 | · | 5,073,000 | 5,073,000 | 5,073,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $261.7K | $246.8K | $199.3K | $118.6K | $80.7K | $47.6K | $27.6K | · | · | · | · | · | |
| Stock-based Comp | $1M | $1M | $1M | $947.2K | · | · | $324.2K | · | · | · | · | · | |
| Amort. of Intangibles | $22.3K | $22.3K | $22.3K | $22.3K | $22.3K | $22.3K | $21.2K | $16.3K | · | · | · | · | |
| Other Non-cash | · | · | $-2M | $2M | $1M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-11M | $-13M | $-8M | $-9M | $-3M | $-5M | · | · | $-21.1K | $-30.2K | $-26.2K | |
| CapEx | $81.7K | $120.2K | $384.1K | $275.2K | $67.1K | $122.4K | $58.4K | · | · | · | · | · | |
| Investing Cash Flow | $-81.7K | $-120.2K | $3M | $-3M | $-67.1K | $-122.4K | $-123.4K | · | · | · | · | · | |
| Stock Issued | · | $836.8K | $3M | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $5M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $7M | $7M | $12M | $12M | $7M | $6M | · | · | · | · | · | |
| Net Change in Cash | · | · | · | · | $3M | $4M | · | · | · | · | · | · | |
| Free Cash Flow | · | $-11M | $-13M | $-8M | $-9M | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 31.3% | 23.4% | -41.4% | -54.9% | · | · | · | · | · | · | · | |
| Operating Margin | · | -344.3% | -612.3% | -5860.2% | -5735.9% | · | · | · | · | · | -6582.9% | -4646.1% | |
| Net Margin | · | -356.7% | -607.4% | -5841.9% | -5584.3% | · | · | · | · | · | -8472.1% | -4688.8% | |
| Pretax Margin | · | -356.7% | -607.4% | · | · | · | · | · | · | · | -8472.1% | -4688.8% | |
| EBITDA Margin | · | -344.3% | -602.1% | -5790.8% | -5690.5% | · | · | · | · | · | -6582.9% | -4646.1% | |
| ROA | · | -182.9% | -113.4% | -96.3% | -156.7% | · | · | · | · | -1562.5% | -6154.0% | -9929.9% | |
| ROE | · | -642.6% | -233.2% | -98.9% | -129.1% | · | · | · | · | 49.0% | 107.6% | 110.4% | |
| ROIC | · | · | · | · | · | · | · | · | · | 28.7% | 59.9% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.1 | 4.1 | 3.9 | 6.2 | · | · | · | · | · | 0.0 | 0.0 | |
| Quick Ratio | · | 0.7 | 3.0 | 3.6 | 5.9 | · | · | · | · | 0.0 | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -3.5 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.5 | 0.2 | 0.0 | 0.0 | · | · | · | · | 0.0 | 0.7 | 2.1 | |
| Inventory Turnover | · | 1.1 | 1.2 | 0.6 | 5.6 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | 39.1 | · | 4.2 | 7.4 | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.03 | $0.26 | $0.59 | $0.55 | · | · | · | · | $-0.02 | $-0.02 | $-0.01 | |
| Revenue / Share | · | $0.13 | $0.11 | $0.01 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.41 | $-0.71 | $-0.47 | · | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.05 | $0.22 | $0.50 | $0.57 | · | · | · | · | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 | · | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 163.5% | 76.9% | 1040.6% | -3.9% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 276.0% | 168.6% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $3M | $2M | $171.2K | $178.1K | $0 | $0 | · | $0 | $0 | $0 | $773 | |
| Net Income TTM | $-4M | $-12M | $-12M | $-10M | $-10M | $-14M | $-7M | · | · | $-47.8K | $-62.9K | $-36.2K | |
| Market Cap | · | $31M | $21M | $27M | $47M | · | · | · | · | · | · | · | |
| P/E | -9.9 | -2.2 | -1.4 | -2.7 | -4.2 | · | · | · | · | · | · | · | |
| P/S | · | 8.8 | 10.9 | 160.1 | 266.3 | · | · | · | · | · | · | · | |
| P/B | · | 37.1 | 3.4 | 2.9 | 7.2 | · | · | · | · | · | · | · | |
| P / Tangible Book | 6.3 | 40.4 | 3.5 | 2.9 | 7.4 | 44.8 | · | · | · | · | · | · | |
| P / Cash Flow | · | -2.8 | -1.7 | -3.6 | -5.5 | · | · | · | · | · | · | · | |
| P / FCF | · | -2.7 | -1.6 | -3.5 | -5.5 | · | · | · | · | · | · | · | |
| Earnings Yield | -10.1% | -46.5% | -73.0% | -37.3% | -23.5% | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $3M | $3M | $2M | $1M | $3M | $272.3K | $825.8K | $1M | $977.6K | $741.8K | $629.9K | $466.2K | $114.6K | $68.8K | |
| Cost of Revenue | $790.5K | $871.8K | $1M | $1M | $781.2K | $615.5K | $1M | $131.2K | $543.9K | $986.9K | $711.3K | $548.1K | $386.2K | $434.7K | $126.9K | $83.8K | |
| Gross Profit | $1M | $990.3K | $2M | $2M | $914.8K | $771.1K | $2M | $141.1K | $281.9K | $390.4K | $266.3K | $193.7K | $243.7K | $31.5K | $-12.3K | $-15.1K | |
| R&D Expense | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $4M | $4M | $3M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-2M | $-1M | |
| Other Non-op | · | · | · | · | · | $19.1K | $9.4K | · | $26.4K | $31.0K | $45.6K | $29.6K | $41.5K | $-26.9K | · | · | |
| Pretax Income | $-2M | $-2M | $-1M | $-2M | $-2M | $-2M | $2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-2M | $-1M | |
| Net Income | $-2M | $-2M | $-1M | $-2M | $-2M | $-2M | $2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-2M | $-1M | |
| EPS (Basic) | $-0.23 | $-0.28 | $-0.03 | $-0.05 | $-0.19 | $-0.44 | $0.06 | $-0.11 | $-0.10 | $-0.11 | $-0.14 | $-0.13 | $-0.20 | $-0.21 | $-0.11 | $-0.09 | |
| EPS (Diluted) | $-0.28 | $-0.28 | $-0.03 | $-0.05 | $-0.19 | $-0.44 | $0.06 | $-0.11 | $-0.10 | $-0.11 | $-0.14 | $-0.13 | $-0.20 | $-0.21 | $-0.11 | $-0.09 | |
| Shares (Basic) | 8,661,624 | 8,484,926 | 50,331,155 | · | 8,100,603 | 5,185,075 | 30,837,524 | · | 27,352,660 | 25,910,478 | 23,995,610 | · | 17,578,871 | 16,414,795 | 16,230,997 | · | |
| Shares (Diluted) | 8,739,505 | 8,484,926 | 50,331,155 | · | 8,100,603 | 5,185,075 | 30,880,415 | · | 27,352,660 | 25,910,478 | 23,995,610 | · | 17,578,871 | 16,414,795 | 16,230,997 | · | |
| EBITDA | $-2M | $-2M | $-2M | · | $-2M | $-3M | $2M | · | $-3M | $-3M | $-3M | · | $-4M | $-3M | $-2M | · |
Bilanço
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $3M | $4M | $7M | $8M | $1M | $1M | $1M | $2M | $2M | $3M | $5M | $3M | $4M | $5M | $8M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $995.4K | $3M | $3M | |
| Receivables | $1M | $2M | $3M | $1M | · | $318.8K | $2M | $176.6K | $410.6K | $555.6K | $543.4K | · | · | $214.0K | $95.3K | $33.2K | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | $2M | $2M | $1M | $903.6K | $704.5K | |
| Prepaid Expense | $318.9K | $283.7K | $154.5K | $141.4K | $233.4K | $208.1K | $194.7K | $216.5K | $261.5K | $407.8K | $260.0K | $263.7K | $278.8K | $370.7K | $325.5K | $296.6K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | $21.3K | · | · | · | · | · | |
| Current Assets | $6M | $7M | $8M | $10M | $10M | $4M | $6M | $5M | $4M | $5M | $5M | $7M | $5M | $6M | $9M | $12M | |
| PP&E (Net) | $202.3K | $230.6K | $244.9K | $259.2K | $314.6K | $334.9K | $381.7K | $416.8K | $472.5K | $496.0K | $505.2K | $525.8K | $586.9K | $522.8K | $334.8K | $353.6K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $976.3K | $973.4K | $939.4K | $893.2K | $860.7K | $891.4K | $777.8K | $551.5K | $539.96B | |
| Accum. Depreciation | $954.6K | $913.2K | $858.8K | $798.8K | $740.1K | $679.1K | $619.0K | $559.5K | $500.9K | $443.4K | $388.1K | $335.0K | $304.5K | $255.0K | $216.7K | $186.36B | |
| Intangibles | $28.2K | $33.8K | $39.4K | $44.9K | $50.5K | $56.1K | $61.7K | $67.3K | $72.8K | $78.4K | $84.0K | $89.6K | $95.2K | $100.7K | $106.3K | $111.9K | |
| Total Assets | $6M | $8M | $9M | $11M | $11M | $4M | $6M | $5M | $5M | $5M | $6M | $8M | $6M | $7M | $10M | $13M | |
| Accounts Payable | $905.7K | $934.2K | $552.3K | $1M | $467.7K | $910.8K | $744.5K | $1M | $759.3K | $780.8K | $760.0K | $685.1K | $958.8K | $953.4K | $861.6K | $927.7K | |
| Accrued Liabilities | $1M | $755.3K | $706.1K | $1M | $958.1K | $852.6K | $826.4K | $1M | $931.7K | $759.6K | $623.2K | $1M | $789.1K | $596.9K | $473.1K | $715.8K | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $121.9K | · | · | · | · | · | · | |
| Current Liabilities | $2M | $2M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $3M | |
| Capital Leases | $73.3K | $92.4K | $110.4K | $143.1K | $175.3K | $207.0K | $237.4K | $194.4K | $209.9K | · | $21.0K | $55.3K | $88.9K | $121.9K | $153.7K | $119.6K | |
| Total Liabilities | $2M | $2M | $2M | $4M | $3M | $3M | $4M | $5M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $3M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $121.9K | · | · | · | · | · | · | |
| Common Stock | $8.7K | $8.6K | $50.4K | $50.0K | $49.8K | $31.4K | $30.8K | $30.8K | $27.8K | $26.3K | $24.8K | $23.9K | $17.9K | $16.9K | $16.2K | $16.2K | |
| Paid-in Capital | $88M | $87M | $86M | $86M | $85M | $77M | $76M | $76M | $75M | $73M | $70M | $69M | $63M | $62M | $61M | $60M | |
| Retained Earnings | $-84M | $-82M | $-80M | $-79M | $-77M | $-75M | $-73M | $-75M | $-72M | $-69M | $-66M | $-63M | $-60M | $-56M | $-53M | $-51M | |
| Stockholders' Equity | $4M | $5M | $6M | $7M | $8M | $1M | $3M | $822.0K | $3M | $4M | $4M | $6M | $4M | $6M | $8M | $10M | |
| Liabilities + Equity | $6M | $8M | $9M | $11M | $11M | $4M | $6M | $5M | $5M | $5M | $6M | $8M | $6M | $7M | $10M | $13M | |
| Shares Outstanding | 8,702,982 | 8,615,532 | 50,413,148 | 50,006,464 | 49,824,780 | 31,385,526 | 30,841,830 | 30,816,499 | 27,846,722 | 26,321,750 | 24,831,090 | 23,928,945 | 17,862,162 | 16,887,738 | 16,238,464 | 16,216,540 |
Nakit Akışı
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $47.0K | $60.0K | $65.5K | $64.3K | $66.6K | $65.6K | $65.1K | $64.1K | $63.1K | $60.9K | $58.7K | $62.5K | $57.0K | $43.9K | $35.9K | $33.4K | |
| Stock-based Comp | $352.8K | $342.1K | $359.3K | $358.6K | $316.7K | $250.2K | $339.2K | $340.4K | $338.6K | $356.9K | $308.6K | $271.2K | $296.4K | $237.6K | $300.2K | · | |
| Amort. of Intangibles | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | $5.6K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | |
| Operating Cash Flow | $-1M | $-1M | $-3M | $-2M | $-1M | $-56.1K | $208.0K | $-3M | $-2M | $-2M | $-4M | $-3M | $-3M | $-4M | $-3M | $1M | |
| CapEx | $19.7K | $38.5K | $40.8K | $10.6K | $43.5K | $3.2K | $24.4K | $36.9K | $14.8K | $31.4K | $37.1K | $57.6K | $139.3K | $175.7K | $11.5K | $66.2K | |
| Investing Cash Flow | $-19.7K | $-38.5K | $-40.8K | $-10.6K | $-43.5K | $-3.2K | $-24.4K | $-36.9K | $-14.8K | $-31.4K | $-37.1K | $-50.1K | $860.7K | $2M | $15.1K | $-3M | |
| Stock Issued | $359.0K | · | · | · | $9M | · | · | $-4M | $2M | $2M | $1M | $0 | $2M | $516.5K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $2M | $2M | $1M | · | · | · | · | · | |
| Financing Cash Flow | $345.0K | $609.6K | $147.8K | $67.0K | $8M | $245.2K | $-509.3K | $3M | $2M | $2M | $1M | $5M | $2M | $662.0K | $-15.7K | $0 | |
| Free Cash Flow | · | · | $-3M | · | · | · | · | · | · | · | $-4M | · | · | · | $-4M | · |
Kârlılık
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.9% | 53.2% | 54.2% | · | 53.9% | 55.6% | 58.9% | · | 34.1% | 28.3% | 27.2% | · | 38.7% | 6.8% | -10.7% | · | |
| Operating Margin | -122.9% | -128.7% | -59.0% | · | -111.2% | -193.3% | 52.3% | · | -338.3% | -209.5% | -346.8% | · | -557.3% | -749.9% | -1557.3% | · | |
| Net Margin | -101.7% | -127.9% | -49.7% | · | -88.5% | -163.8% | 54.5% | · | -335.1% | -207.3% | -342.1% | · | -550.7% | -755.7% | -1512.3% | · | |
| Pretax Margin | -101.7% | -127.9% | -49.7% | · | -88.5% | -163.8% | 54.5% | · | -335.1% | -207.3% | -342.1% | · | -550.7% | -755.7% | -1512.3% | · | |
| EBITDA Margin | -122.9% | -128.7% | -59.0% | · | -111.2% | -193.3% | 52.3% | · | -338.3% | -209.5% | -346.8% | · | -557.3% | -749.9% | -1526.0% | · | |
| ROA | -23.6% | -39.6% | -19.1% | · | -19.1% | -46.1% | 29.0% | · | -51.9% | -45.3% | -43.2% | · | -40.0% | -36.9% | -14.6% | · | |
| ROE | -33.6% | -76.8% | -30.8% | · | -26.8% | -91.2% | 48.6% | · | -79.8% | -60.8% | -53.1% | · | -47.7% | -43.0% | -16.3% | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 4.2 | 6.4 | · | 7.1 | 2.1 | 3.6 | · | 2.4 | 3.1 | 3.7 | · | 2.8 | 4.1 | 6.7 | · | |
| Quick Ratio | 1.5 | 2.8 | 4.9 | · | 5.6 | 0.9 | 2.2 | · | 1.2 | 1.9 | 2.3 | · | 1.8 | 3.1 | 5.8 | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.4 | · | 0.2 | 0.3 | 0.5 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.4 | 0.4 | 0.7 | · | 0.4 | 0.4 | 0.8 | · | 0.3 | 0.8 | 0.6 | · | 0.4 | 0.7 | 0.2 | · | |
| Receivables Turnover | 3.6 | 1.7 | 1.1 | · | · | 3.2 | 2.2 | · | 4.0 | 3.6 | 3.1 | · | · | 4.4 | 1.7 | · |
Hisse Başına
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.43 | $0.59 | $0.13 | · | $0.16 | $0.04 | $0.10 | · | $0.11 | $0.15 | $0.18 | · | $0.22 | $0.33 | $0.50 | · | |
| Revenue / Share | $0.23 | $0.22 | $0.06 | · | $0.03 | $0.04 | $0.11 | · | $0.03 | $0.05 | $0.04 | · | $0.04 | $0.03 | $0.01 | · | |
| Cash Flow / Share | · | · | $-0.06 | · | · | · | $0.01 | · | · | · | $-0.16 | · | · | · | $-0.22 | · | |
| Cash / Share | $0.24 | $0.33 | $0.07 | · | $0.16 | $0.04 | $0.04 | · | $0.06 | $0.09 | $0.11 | · | $0.17 | $0.21 | $0.29 | · | |
| EPS (TTM) | $-0.64 | $-0.55 | $-0.71 | · | $-0.68 | $-0.59 | $-0.26 | · | $-0.48 | $-0.58 | $-0.68 | · | $-0.61 | $-0.58 | $-0.56 | · |
Değerleme (TTM)
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $9M | $9M | · | $7M | $6M | $6M | · | $4M | $4M | $3M | · | $1M | $681.6K | $252.0K | · | |
| Net Income TTM | $-7M | $-7M | $-7M | · | $-5M | $-7M | $-7M | · | $-12M | $-13M | $-13M | · | $-10M | $-9M | $-9M | · | |
| Market Cap | $26M | $7M | $38M | · | $34M | $27M | $25M | · | $22M | $32M | $39M | · | $21M | $27M | $19M | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $29M | · | · | · | · | · | · | |
| P/E | -4.8 | -1.4 | -1.1 | · | -1.0 | -1.4 | -3.2 | · | -1.7 | -2.1 | -2.3 | · | -2.0 | -2.8 | -2.1 | · | |
| P/S | 2.8 | 0.7 | 4.4 | · | 5.1 | 4.6 | 4.4 | · | 5.7 | 8.5 | 13.9 | · | 16.8 | 39.9 | 77.3 | · | |
| P/B | 7.0 | 1.3 | 6.0 | · | 4.1 | 23.7 | 8.7 | · | 7.4 | 8.2 | 8.9 | · | 5.5 | 4.9 | 2.4 | · | |
| P / Tangible Book | 7.1 | 1.3 | 6.0 | · | 4.2 | 24.9 | 8.9 | · | 7.6 | 8.4 | 9.1 | · | 5.6 | 5.0 | 2.4 | · | |
| P / Cash Flow | · | · | -12.3 | · | · | · | 122.4 | · | · | · | -10.3 | · | · | · | -5.6 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 7.9 | · | · | · | · | · | · | |
| Earnings Yield | -21.1% | -70.8% | -93.7% | · | -100.3% | -69.4% | -31.5% | · | -60.0% | -48.3% | -43.0% | · | -50.8% | -36.0% | -46.7% | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Gelir | $9M | $3M | $2M | $171.2K | $178.1K |
| Brüt Kâr Marjı % | · | 31.3% | 23.4% | -41.4% | -54.9% |
| Faaliyet Kâr Marjı % | · | -344.3% | -612.3% | -5860.2% | -5735.9% |
| Net Gelir | $-4M | $-12M | $-12M | $-10M | $-10M |
| Seyreltilmiş Hisse Başı Kâr | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 |
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Cari Oran | · | 2.1 | 4.1 | 3.9 | 6.2 |
| Cari Oran | · | 0.7 | 3.0 | 3.6 | 5.9 |
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | $-11M | $-13M | $-8M | $-9M |
Kurumsal Sahipler (13F) 3 dosya · $1.2M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
3
Tutulan Değer
$1.2M
Yeni pozisyonlar
0
Çıkan pozisyonlar
29
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 0 | 29 | 0 | 2 | · |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır. Önceki çeyreğe göre değişim gösterilmiyor: başvuru sahibi kapsamı, güvenilir bir karşılaştırma için bu iki çeyrek arasında çok fazla farklılık göstermektedir.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.196.303 | 1.578.237 | 99,29% | Hisse senetleri |
| Princeton Global Asset Management LLC | $8.527 | 2.805 | 0,71% | Hisse senetleri |
| Quent Capital, LLC | $18 | 6 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 8 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Wade Fredrickson ×3 başvurular | 29 Ekim 2019 | · | İlk başvuru | · | SEC |
| Lifestyle Healthcare LLC ×3 başvurular | 08 Mayıs 2018 | · | İlk başvuru | Pasif yatırım | SEC |
| Amer Samad ×2 başvurular | 07 Ağustos 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Mark Christianson | 26 Temmuz 2017 | · | İlk başvuru | M&A / satış | SEC |
| David A. Rosa | 26 Temmuz 2017 | · | İlk başvuru | M&A / satış | SEC |
| Chromium 24 LLC | 13 Temmuz 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Linda LaRae Rock | 06 Eylül 2013 | · | İlk başvuru | Pasif yatırım | SEC |
| Lecia Walker | 05 Haziran 2013 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 18 içeriden öğrenenler · 10 yöneticiler · 6 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| David A Rosa | CEO & President | 28 Ağustos 2026 A | 1.080.132 | 0 | 0 | $0 |
| Christopher Volker | Chief Financial Officer | 28 Ağustos 2026 A | 75.000 | 0 | 0 | $0 |
| Ronald W. Mcclurg | Chief Financial Officer | 17 Nisan 2025 A | 444.117 | 0 | 0 | $0 |
| Emily J. Johns | Chief Administrative Officer | 28 Ağustos 2026 A | · | 0 | 0 | $0 |
| David J. Wambeke | Chief Business Officer | 28 Ağustos 2026 A | 199.999 | 2 | 0 | $736.999 |
| Steve Mertens | Chief Technology Officer | 28 Ağustos 2026 A | 152.141 | 0 | 0 | $0 |
| Mark Christianson | Market Development Director | 28 Ağustos 2026 A | 20.692 | 0 | 6 | $-54.879 |
| Hijaz Haris | VP of Marketing | 26 Nisan 2021 A | · | 0 | 0 | $0 |
| Scott Heuler | Vice President of Sales | 01 Ocak 2019 A | · | 0 | 0 | $0 |
| Thomas Bachinski | Chief Development Officer | 20 Temmuz 2017 A | 215.453 | 0 | 0 | $0 |
| Jason Richard Mills | Yönetim kurulu üyesi | 03 Nisan 2026 A | 49.687 | 0 | 0 | $0 |
| Edward Andrle | Yönetim kurulu üyesi | 03 Nisan 2026 A | 133.932 | 0 | 0 | $0 |
| Paul Buckman | Yönetim kurulu üyesi | 03 Nisan 2026 A | 178.733 | 0 | 0 | $0 |
| Suraj Kalia | Yönetim kurulu üyesi | 05 Kasım 2019 A | 14.006 | 0 | 0 | $0 |
| Amer Samad | Yönetim kurulu üyesi | 20 Temmuz 2017 J | 15.728 | 0 | 0 | $0 |
| Wade Fredrickson | 10% sahip | 21 Ekim 2019 J | 2.113.459 | 0 | 0 | $0 |
| MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH | 10% sahip | 03 Nisan 2019 J | 572.846 | 0 | 0 | $0 |
| Jeffrey S Mathiesen | · | 03 Nisan 2026 A | 156.343 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
NMTC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$8.00
+614,3%
3 33,3%
Güçlü Al
5 55,6%
Al
1 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-09-28Ortalama hedef $7.27 +548,8%
← Tüm hedeflerin altında
Mevcut fiyat $1.12
Düşük$5.00
Ortalama$7.27
Yüksek$8.80
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| NMTC | · | -9.9 | 163.5% | · | · | · |
| CTSO | · | -4.9 | 4.1% | · | · | · |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| AEMD | $3M | -0.2 | · | · | -134.5% | · |
| BMRA | · | -1.8 | -16.2% | · | · | · |
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| CODX | $11M | -0.1 | -84.1% | -7533.6% | -151.8% | 64.3% |
| AMIX | · | · | · | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026